Literature DB >> 871094

Histamine and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress ulcer formation by (+)-catechin, an inhibitor of specific histidine decarboxylase in vitro.

H J Reimann, W Lorenz, M Fischer, R Frölich, H J Meyer, A Schmal.   

Abstract

Acute haemorrhagic lesions in the oesophagus, stomach and duodenum ('stress ulcers') occur relatively often under clinical conditions and are always dangerous to the patient (lethality rate about 70%). Since conservative and surgical treatment are without significant success up to now, prevention by adaptation to stressors or by administration of drugs seems mandatory. An improved technique for producing acute gastric lesions in rats by immobilization and a new method for assessing this disease in the animals is presented in this communication. High precision is obtained within a single experimental series especially from day to day. Since histamine was suggested to be involved in the pathogenesis of stress ulcer disease, (+)-catechin, a rather specific inhibitor of specific histidine decarboxylase from rat stomach, was tested in immobilized rats. It prevented the formation of acute gastric lesions by 80% in seven series of experiments lasting for half a year. Since the drug has low toxicity in man, it is recommended for clinical trials.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871094     DOI: 10.1007/bf01964883

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Proceedings: Effects of (+)-catechin on several enzymes of histamine metabolism and on stress ulcer formation in the female rat.

Authors:  W Lorenz; H J Reimann; J Kusche; H Barth; A Schmal; H Nusimé; G Schülle; R Froelich; J Schmidt; R Raabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Use of the restrained rat technique for study of the antiulcer effect of drugs.

Authors:  H M HANSON; D A BRODIE
Journal:  J Appl Physiol       Date:  1960-03       Impact factor: 3.531

3.  A method for the production of stress erosion in the mouse stomach and related pharmacological studies.

Authors:  S Yano; M Harada
Journal:  Jpn J Pharmacol       Date:  1973-02

4.  [Histamine liberation in man and pathogenesis of stress ulcer].

Authors:  W Lorenz; A Doenicke; G Mann; R Uhlig; H Rohde
Journal:  Z Gastroenterol       Date:  1973-05       Impact factor: 2.000

5.  Specific histidine decarboxylases in the gastric mucosa of man and other mammals. Determination, location and properties.

Authors:  W Lorenz; S Halbach; M Gerant; E Werle
Journal:  Biochem Pharmacol       Date:  1969-10       Impact factor: 5.858

Review 6.  [New viewpoints in etiopathology of stress and steroids induced ulcer].

Authors:  W Lorenz; G Feifel
Journal:  Dtsch Med Wochenschr       Date:  1970-09-04       Impact factor: 0.628

7.  Exertion ulcers in the rat.

Authors:  A Robert; J I Northam; J E Nezamis; J P Phillips
Journal:  Am J Dig Dis       Date:  1970-05

8.  Gastric mucosal ulceration following vasoactive agents. A new experimental model.

Authors:  S Sethbhakdi; C J Pfeiffer; J L Roth
Journal:  Am J Dig Dis       Date:  1970-03

9.  Inhibition of gastric acid secretion and ulcer formation in the rat by orally-administered 11-deoxyprostaglandin analogues: 15-hydroxy-16,16-dimethyl-9-oxoprost-5,13-dienoic acids.

Authors:  W Lippmann
Journal:  Prostaglandins       Date:  1974-08-10

10.  Histamine synthesis in man: inhibition by 4-bromo-3-hydroxybenzyloxyamine.

Authors:  R J Levine
Journal:  Science       Date:  1966-11-25       Impact factor: 47.728

  10 in total
  10 in total

1.  Action of FPL 52694 on gastric acid secretion in the healthy human stomach.

Authors:  H J Reimann; U Schmidt; B Ultsch; T J Sullivan; P Wendt
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

2.  The gastric antisecretory activity of 3-methoxy-5,7,3'4'-tetrahydroxyflavan (ME)--a specific histidine decarboxylase inhibitor in rats.

Authors:  N S Parmar; G Hennings
Journal:  Agents Actions       Date:  1984-10

3.  Peptide inhibition of mammalian histidine decarboxylase.

Authors:  L Hammar; U Ragnarsson
Journal:  Agents Actions       Date:  1979-10

4.  The pathogenesis of cianidanol-induced fever.

Authors:  P T Daniel; J Holzschuh; P A Berg
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Gastric protection by meciadanol. A new synthetic flavonoid inhibiting histidine decarboxylase.

Authors:  S J Konturek; M E Kitler; T Brzozowski; T Radecki
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

6.  Effects of FPL-52694, a new mast cell stabilizer, on gastric secretion and various acute gastric lesions in rats.

Authors:  K Takeuchi; Y Ishihara; H Kunimi; S Okabe
Journal:  Agents Actions       Date:  1984-06

7.  The disposition of 3-O-methyl-(+)-catechin in the rat and the marmoset following oral administration.

Authors:  A M Hackett; L A Griffiths
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

Review 8.  Histidine decarboxylase inhibition: a novel approach towards the development of an effective and safe gastric anti-ulcer drug.

Authors:  N S Parmar; G Hennings; O P Gulati
Journal:  Agents Actions       Date:  1984-12

9.  Gastric antiulcerogenic and hypokinetic activities of Terminalia fagifolia Mart. & Zucc. (Combretaceae).

Authors:  Paulo Humberto M Nunes; Maria do Carmo C Martins; Rita de Cássia M Oliveira; Mariana H Chaves; Elcilene A Sousa; José Roberto S A Leite; Leiz Maria Véras; Fernanda Regina C Almeida
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

10.  Protective effect of (+)-catechin against lipopolysaccharide-induced inflammatory response in RAW 264.7 cells through downregulation of NF-κB and p38 MAPK.

Authors:  M A Sunil; V S Sunitha; Prasanthkumar Santhakumaran; Mohind C Mohan; Midhun Sebastian Jose; E K Radhakrishnan; Jyothis Mathew
Journal:  Inflammopharmacology       Date:  2021-06-11       Impact factor: 4.473

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.